-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
- Horizon Therapeutics Public Ltd Co Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $8.18M, a 115% increase year-over-year.
- Horizon Therapeutics Public Ltd Co Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $5.86M.
- Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2022 was $5.45M.
- Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2021 was -$71.7M, a 705% decline from 2020.
- Horizon Therapeutics Public Ltd Co annual Income Tax Expense (Benefit) for 2020 was $11.8M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)